Sign in

Trial result ·

A pilot study on the impact of Hydroxiram D supplementation on nutritional status and sarcopenia-related parameters.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study tested Hydroxiram D in people with cirrhosis from fatty liver disease. Their cirrhosis was compensated, rated Child-Pugh A. The product mixes amino acids, a compound called HMB, and vitamin D. It was a pilot trial at one center, with groups set by chance. One group got the product plus usual care for 6 months. The other group got usual care alone. The main test was phase angle, a body measure. They also checked muscle mass, grip strength and walking speed.

What they found

After 6 months, phase angle changed in a better way with the product. It went up by 0.36 degrees in the product group. It went down by 0.45 degrees in the usual care group. This gap was statistically significant, with p = 0.046. Muscle mass, grip strength and walking speed did not differ clearly. Still, these results leaned toward the product. No harms from the product were seen.

What it means for patients

The authors say the product was linked to a better phase angle change. Muscle results showed trends in the same direction. They see these results as ideas to test, not as proof. They say larger trials are needed to confirm if it works.

Why it is not certain yet

This was a pilot trial at a single center. The authors say the findings only raise ideas to test. The muscle results were not statistically significant. Some extra analyses were only meant to help plan future studies. The trial lasted 6 months, so long-term effects are not known. The authors call for larger, blinded trials that are registered first.

Source

A pilot study on the impact of Hydroxiram D supplementation on nutritional status and sarcopenia-related parameters.

PubMed · PMID 43018676

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Liver cirrhosis publications